These emerging treatments , including Rybelsus, belong to a class of drugs called GLP-1 receptor agonists . Primarily intended for controlling type 2 diabetes , they work by encouraging the pancreas to produce adequate the hormone insulin and curbing increased glucose levels. Furthermore , their ability to support slimming has led to increased disc